# Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients

> **NCT05708508** · PHASE3 · RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 144 (estimated)

## Conditions studied

- Kidney Transplant Infection

## Interventions

- **DRUG:** ROVALCYTE

## Key facts

- **NCT ID:** NCT05708508
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-28
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05708508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05708508, "Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients". Retrieved via AI Analytics 2026-08-20 from https://api.ai-analytics.org/clinical/NCT05708508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*